These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 824540

  • 21. Palliative treatment with oral Estracyte in disseminated prostatic carcinoma.
    Welvaart K.
    Arch Chir Neerl; 1975; 27(3):193-8. PubMed ID: 55103
    [Abstract] [Full Text] [Related]

  • 22. Extended therapy of stage D carcinoma of the prostate with oral estramustine phosphate.
    Mittelman A, Shukla SK, Murphy GP.
    J Urol; 1976 Apr; 115(4):409-12. PubMed ID: 1263317
    [Abstract] [Full Text] [Related]

  • 23. Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate.
    Mittelman A, Shukla SK, Welvaart K, Murphy GP.
    Cancer Chemother Rep; 1975 Apr; 59(1):219-23. PubMed ID: 1093669
    [Abstract] [Full Text] [Related]

  • 24. [Use of Estracyt in cases of prostatic neoplasms].
    Wesolowski S, Czaplicki M, Cieślak A.
    Pol Przegl Chir; 1976 Jun; 48(6A):783-9. PubMed ID: 951325
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical study of estramustine phosphate disodium (Estracyt) on prostatic cancer--results of long-term therapy for 38 patients with prostatic cancer].
    Asakawa M, Wada S, Hayahara N, Yayumoto R, Kishimoto T, Maekawa M, Morikawa Y, Kawakita J, Umeda M, Horii A.
    Hinyokika Kiyo; 1990 Nov; 36(11):1361-9. PubMed ID: 2288316
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T, Mitsuya H, Honda N, Fukatu H, Aota Y, Shinoda M, Yoshida K, Sobajima T, Ohishi M, Tsumura Y.
    Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Estramustine phosphate (Estracyt) treatment of T3-T4 prostatic carcinoma.
    Veronesi A, Zattoni F, Frustaci S, Galligioni E, Tirelli U, Trovó G, Tumolo S, Merlo A, Artuso G, Cosciani-Cunico S, Grigoletto E.
    Prostate; 1982 Jan; 3(2):159-64. PubMed ID: 7088731
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC.
    Wis Med J; 1976 Sep; 75(9):S89-90. PubMed ID: 969557
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I.
    Orv Hetil; 1982 Jan 31; 123(5):287-9. PubMed ID: 7063244
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
    Sandberg AA, Rosenthal H, Mittelman A, Murphy GP.
    Urology; 1975 Jul 31; 6(1):17-21. PubMed ID: 1145919
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.